What is Janus Living 's biotech — operating income?

Janus Living (JAN) reported biotech — operating income of -$177K in Q1 2026.

What does biotech — operating income mean?

Represents the profit or loss generated specifically by the biotech business segment from its core operations. It excludes non-operating income, interest, and taxes to isolate the segment's fundamental operational efficiency.

Janus Living JAN Biotech — Operating Income

Other segment segments

Total Reportable Segments

-$10.08M—

Corporate And Other

-$2.27M-3.7%

Fintech

-$1.64M—

Similar metrics at other companies

DHRBiotechnology — Operating Income (Loss)

$534M+21.1%

PLYXOperating Income

-$1.96M+61.2%

DHRLife Sciences — Operating Income (Loss)

$225M+11.9%

SGPOperating Income

-$15.41M-108%

TMOLaboratory Products and Biopharma Services — Operating Income (Loss)

$778M+6.4%

MANEOperating Income

-$29.86M-131%

Other financials

Income statement

See full

Revenue$4.7M-2.8%

Gross profit$3.6M+85.6%

Operating income-$2.7M-41.0%

Net income-$271.5M-11,250%

EPS (diluted)-$2.14-1,327%

Balance sheet

See full

Cash & equivalents$10.5M-2.7%

Total debt$107.0K-99.4%

Total equity$889.7M+3,976%

Total assets$959.7M+1,130%

Cash flow

See full

Operating cash flow-$12.3M-764%

CapEx$2.8K—

Free cash flow-$1.8M—

Valuation

See full

Market cap$5.56B+43,568%

Enterprise value$5.55B+26,232%

P/S231.5×+231×

Profitability

See full

Gross margin46.5%+1.2pp

Operating margin-99.7%-717pp

Net margin-2,552.7%-2,601pp

FCF margin-29.7%—

Returns & leverage

See full

Return on equity-134.6%-791pp

Debt / equity0×-0.5×

Current ratio0.8×0.0×

Where this comes from

Reported directly by Janus Living in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Janus Living ’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janus Living 's biotech — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janus Living 's biotech — operating income?: Janus Living (JAN) reported biotech — operating income of -$177K in Q1 2026.
What does biotech — operating income mean?: Represents the profit or loss generated specifically by the biotech business segment from its core operations. It excludes non-operating income, interest, and taxes to isolate the segment's fundamental operational efficiency.